Adagene is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
Adagene is a startup founded in 2015 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Adagene is a Nasdaq-listed, clinical-stage biopharmaceutical company that discovers and designs therapeutic antibodies and antibody-based cancer immunotherapies using proprietary protein engineering and discovery platforms. The company develops wholly owned and partnered antibody programs, including clinical-stage candidates targeting oncology indications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.